Sweden· SE-20180731000068
Tremfya (OnePress) 100 mg Injektionsvätska, lösning i förfylld injektionspenna
A medicinal product containing guselkumab, registered in Sweden by Janssen-Cilag International NV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Guselkumab
- Manufacturer
- Janssen-Cilag International NV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20180731000068
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Guselkumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTREMFYAJanssen-Cilag International N.V., Beerse
- United KingdomTremfya 100mg/1ml solution for injection pre-filled syringesJanssen-Cilag Ltd
- SpainTREMFYA 100 MG ONEPRESS SOLUCION INYECTABLE EN PLUMA PRECARGADAJanssen-Cilag International N.V
- BelgiumTremfya 100 mgJanssen-Cilag International
- NorwayTremfyaJanssen-Cilag International N.V.
- IcelandTremfyaJanssen-Cilag International NV*
- SwitzerlandTremfya 100 mg/1 ml, Injektionslösung im FertigpenJanssen-Cilag AG
- NetherlandsTremfya 100 mg OnePress oplossing voor injectie in een voorgevulde penJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tremfya
- Liechtenstein · Tremfya
- Norway · Tremfya
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7b21ce5-7a78-4361-9384-3d4add84b006 GET /v1/drugs/b7b21ce5-7a78-4361-9384-3d4add84b006?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20180731000068",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20180731000068",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/tremfya"
}See everything about guselkumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.